Matches in SemOpenAlex for { <https://semopenalex.org/work/W2994697984> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W2994697984 endingPage "890" @default.
- W2994697984 startingPage "890" @default.
- W2994697984 abstract "Introduction: Whether sickle cell disease (SCD) or its primary treatment, hydroxyurea (HU), limits reproductive potential in affected women is unknown. Females are born with a finite number of eggs. Anti-Mullerian Hormone (AMH), produced by immature ovarian follicles, is an established method to measure ovarian reserve. Two studies of AMH, one in adolescents with SCD and another in adult women with SCD exist, but neither normal AMH values nor the effect of HU on AMH are established in girls and women with SCD. The purpose of this study is to evaluate AMH levels in women who participated in the seminal study that led to FDA-approval for HU in adults with SCD, the Multi-Center Study of Hydroxyurea (MSH). Methods: The MSH was a randomized placebo-controlled trial (RCT) of HU. The RCT demonstrated HU's efficacy, so a 10-year MSH extension study was conducted to assess HU's potential for mutagenesis, teratogenesis and oncogenesis. Although no samples from the RCT remain, serum samples (n=285) were available for many women in the follow-up study (n=93). We measured AMH in these samples using the CLIA-certified electrochemiluminescence assay in clinical use at our institution (Esoterix Labs, Calabasas Hills, CA). The assay's reference median AMH in women ages 26 - 30 years is 4.20 ng/mL, and in women 36 - 40 years is 1.69 ng/mL. The assay's lower limit of detection is 0.015ng/mL. Samples with AMH levels beneath the detection limit were run in duplicate when sufficient sample existed; this did not change any results. Here, we report AMH levels in female subjects (n=57) with a serum sample from the first annual follow-up visit (AV01). Descriptive statistics with median values reported for non-parametric variables (Mann Whitney U Test) were performed. AMH < 1 is associated with diminished ovarian reserve, a risk factor for shortened reproductive lifespan, infertility and poor outcomes with assisted reproductive technology. Therefore, we categorized AMH as normal (>/= 1 ng/ml) and low (<1 ng/ml). We initially evaluated factors associated with low AMH using the chi-squared and Mann Whitney U test for categorical and continuous variables, respectively. We then performed logistic regression analysis to evaluate the independent association of age, BMI, absolute neutrophil count (ANC), mean corpuscular volume (MCV) and months of HU exposure with AMH levels. Results: Samples from the first post-study visit were available for 57 women; the median time to first post-study visit was 31 months (IQR 6.5) after RCT closure. Median values for the cohort were: AMH, 0.306ng/ml (IQR 1.162), age, 32.50 years (IQR 11), MCV, 102.0 fl (IQR 15.8), and HU exposure, 23.92 months (IQR 30.72). Figure 1 shows AMH distribution in the cohort. AMH levels were low in 77% (44 of 57) of the cohort. Table 1 compares patient characteristics of subjects with low AMH (n=44) versus normal AMH (n=13). In univariate analysis, subjects with low AMH were older (34.5 vs 24.5, p<0.001) and had larger MCV (105.55 vs 95.80, p=0.002). Median HU exposure time did not reach significance between low and normal AMH groups (33 months vs 17 months, p=0.055). In a logistic regression model, age [OR 1.252, (95% CI 1.066, 1.014), p=0.006] and MCV [OR 1.139, (95% CI 1.014, 1.279), p=0.028] were associated with low AMH while duration of exposure to HU [OR 1.01 (95% CI 0.91, 1.09), p=0.364], body mass index [OR 1.07 (95% CI 0.91, 1.25), P=0.442] and ANC [OR 1.39 (95% CI 0.91, 2.13), p=0.127) were not associated with low AMH. Conclusions: Most women (77%) in this cohort had low AMH, associated with older age and higher MCV. This preliminary analysis raises concerns about diminished ovarian reserve in women with SCD. Although months of HU exposure was not associated with low AMH, HU exposure does not account for adherence, which is a major limitation in most sickle cell studies. MCV which increases with consistent HU use and is a biological proxy measure of the last 3-months of HU adherence, was associated with low AMH. Ovarian reserve was not a planned endpoint in the MSH. A prospective study of ovarian reserve in women with SCD is needed to understand how the physiology of SCD itself or exposure to HU may influence multiple fertility endpoints. Disclosures Chaturvedi: Shire/Takeda: Research Funding; Sanofi: Consultancy; Alexion: Consultancy. Lanzkron:PCORI: Research Funding; NIH: Research Funding; Pfizer: Research Funding; Global Blood Therapeutics: Research Funding; Ironwood: Research Funding; HRSA: Research Funding." @default.
- W2994697984 created "2019-12-26" @default.
- W2994697984 creator A5012837258 @default.
- W2994697984 creator A5022433604 @default.
- W2994697984 creator A5047512989 @default.
- W2994697984 creator A5059007999 @default.
- W2994697984 creator A5063648770 @default.
- W2994697984 creator A5070142314 @default.
- W2994697984 date "2019-11-13" @default.
- W2994697984 modified "2023-09-30" @default.
- W2994697984 title "Anti-Mullerian Hormone, a Measure of Ovarian Reserve, Is Low in Female Subjects in the Multi-Center Study of Hydroxyurea" @default.
- W2994697984 doi "https://doi.org/10.1182/blood-2019-122137" @default.
- W2994697984 hasPublicationYear "2019" @default.
- W2994697984 type Work @default.
- W2994697984 sameAs 2994697984 @default.
- W2994697984 citedByCount "1" @default.
- W2994697984 countsByYear W29946979842022 @default.
- W2994697984 crossrefType "journal-article" @default.
- W2994697984 hasAuthorship W2994697984A5012837258 @default.
- W2994697984 hasAuthorship W2994697984A5022433604 @default.
- W2994697984 hasAuthorship W2994697984A5047512989 @default.
- W2994697984 hasAuthorship W2994697984A5059007999 @default.
- W2994697984 hasAuthorship W2994697984A5063648770 @default.
- W2994697984 hasAuthorship W2994697984A5070142314 @default.
- W2994697984 hasBestOaLocation W29946979841 @default.
- W2994697984 hasConcept C126322002 @default.
- W2994697984 hasConcept C168563851 @default.
- W2994697984 hasConcept C2776600139 @default.
- W2994697984 hasConcept C2777688143 @default.
- W2994697984 hasConcept C2778780466 @default.
- W2994697984 hasConcept C2779234561 @default.
- W2994697984 hasConcept C29456083 @default.
- W2994697984 hasConcept C54355233 @default.
- W2994697984 hasConcept C71315377 @default.
- W2994697984 hasConcept C71924100 @default.
- W2994697984 hasConcept C86803240 @default.
- W2994697984 hasConceptScore W2994697984C126322002 @default.
- W2994697984 hasConceptScore W2994697984C168563851 @default.
- W2994697984 hasConceptScore W2994697984C2776600139 @default.
- W2994697984 hasConceptScore W2994697984C2777688143 @default.
- W2994697984 hasConceptScore W2994697984C2778780466 @default.
- W2994697984 hasConceptScore W2994697984C2779234561 @default.
- W2994697984 hasConceptScore W2994697984C29456083 @default.
- W2994697984 hasConceptScore W2994697984C54355233 @default.
- W2994697984 hasConceptScore W2994697984C71315377 @default.
- W2994697984 hasConceptScore W2994697984C71924100 @default.
- W2994697984 hasConceptScore W2994697984C86803240 @default.
- W2994697984 hasIssue "Supplement_1" @default.
- W2994697984 hasLocation W29946979841 @default.
- W2994697984 hasOpenAccess W2994697984 @default.
- W2994697984 hasPrimaryLocation W29946979841 @default.
- W2994697984 hasRelatedWork W1551507320 @default.
- W2994697984 hasRelatedWork W2036971906 @default.
- W2994697984 hasRelatedWork W2074452363 @default.
- W2994697984 hasRelatedWork W2192240260 @default.
- W2994697984 hasRelatedWork W2316398142 @default.
- W2994697984 hasRelatedWork W2499202510 @default.
- W2994697984 hasRelatedWork W2557371649 @default.
- W2994697984 hasRelatedWork W2770905176 @default.
- W2994697984 hasRelatedWork W3135512545 @default.
- W2994697984 hasRelatedWork W4308370648 @default.
- W2994697984 hasVolume "134" @default.
- W2994697984 isParatext "false" @default.
- W2994697984 isRetracted "false" @default.
- W2994697984 magId "2994697984" @default.
- W2994697984 workType "article" @default.